Interleukin inhibitors Ustekinumab is an antagonist of the p40 subunit of pro-inflammatory cytokines interleukin-12 and interleukin-23, recently licensed for induction and maintenance therapy in CD and UC[9597]
This targeted mechanism allows enhanced fat oxidation and reduced lipogenesis, particularly in visceral and abdominal fat depots, making it a key subject in obesity and metabolic optimization research
Prolonged exposure of diluted liquid formulations to temperature fluctuations leads to concentration loss via adsorption to vial walls or gradual chemical breakdown
Lomonte B, Angulo Y, Sasa M, Gutierrez JM (2009) The phospholipase A2 homologues of snake venoms: biological activities and their possible adaptive roles
The reaction is catalyzed by a family of enzymes called Glutathione S-transferases (GSTs), which facilitate a nucleophilic attack, covalently binding the sulfur atom of glutathione directly to the toxic Phase I metabolite